Sumanta K. Pal, Vice Chair of Academic Affairs and Professor at City of Hope, shared on X:
“A wonderful moment meeting Drs. Ugrakli and Artac from Necmettin Erbakan Üniversitesi at ESMO26.
Dr. Ugrakli noted that she modelled her study of nivolumab +/- BL-04 (a Bifidobacterium animalis strain) after seeing Nazli Dizman discuss her work related to CBM588.
Take a close look – interesting early OS signal. There are so many hidden gems in the poster sessions, do try to attend!”
Other articles about nivolumab on OncoDaily.